Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402217 · ClinicalTrials.gov registry record
Patient Centered Postpartum Contraception App
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 20
- Enrollment target
NCT03402217: Completed study, sponsored by University of Chicago.
NCT03402217 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03402217 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study will evaluate a smart phone-based application ("app") designed to inform pregnant women ages 15-25 about their contraception options. The goal of this research will be to evaluate the usability, feasibility and acceptability of this app.
Primary Outcome
Feasibility, acceptability and usability of application. Mean of each item is reported. Each item has a possible score of 1-5, 1 = strongly disagree; 5= strongly agree. Higher scores indicate a better results for all items except "I found the app too complex to understand," "I think I would need tech support to use this app," "I thought there was too much inconsistency in app," "I found the app cumbersome to use," and "I needed to learn a lot before I could get going," where a lower score is a b
Interventions
- BEHAVIORAL Patient Centered Postpartum Contraception App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2019-01-07 |
What the finished NCT03402217 record still lists
NCT03402217 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patient Centered Postpartum Contraception App is the first listed.
NCT03402217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03402217 about?
NCT03402217 is a clinical study titled "Patient Centered Postpartum Contraception App". This study will evaluate a smart phone-based application ("app") designed to inform pregnant women ages 15-25 about their contraception options. The goal of this research will be to evaluate the usability, feasibility and acceptability of this app.
What is the current status of trial NCT03402217?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-05-18. Estimated completion is 2019-01-07.
What interventions are being tested in trial NCT03402217?
The interventions under investigation include: Patient Centered Postpartum Contraception App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03402217?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI